Parallel Advisors, LLC Akouos, Inc. Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 28, 2022
SELL
$4.16 - $9.08 $108 - $236
-26 Reduced 72.22%
10 $0
Q4 2021

Jan 20, 2022
BUY
$7.65 - $11.38 $198 - $295
26 Added 260.0%
36 $0
Q3 2021

Nov 02, 2021
SELL
$9.93 - $13.59 $148 - $203
-15 Reduced 60.0%
10 $0
Q1 2021

Apr 23, 2021
BUY
$13.87 - $21.04 $346 - $526
25 New
25 $0

About Akouos, Inc.

AKUS Quotes by TradingView
  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email